Affiliation:
1. Department of Pharmaceutical & Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA
Abstract
The transient receptor potential, the melastatin (TRPM) subfamily, which consists of eight known members, appears to have significant importance in melanoma progression, treatment, and prognosis. As several members were originally cloned from cancerous tissue, initial studies aimed towards identifying TRPM involvement in cancer progression and tumorigenesis. For relevance in skin cancer, previous research has shown roles for several TRPM members in skin cancer progression, growth, and patient prognosis. One unique member, TRPM2, appears to have notable therapeutic potential in the treatment of melanoma. Previous and recent studies have demonstrated increased TRPM2 expression levels in melanoma, as well as important roles for TRPM2 in melanoma growth, proliferation, and survival. TRPM2 is thus an emerging target in the treatment of melanoma, where TRPM2 antagonism may offer an additional treatment option for melanoma patients in the future.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference81 articles.
1. Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., and Offidani, A. (2022). The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutic Approaches. Antioxidants, 11.
2. Cellular functions of transient receptor potential channels;Dadon;Int. J. Biochem. Cell Biol.,2010
3. Role of TRPM in melanocytes and melanoma;Guo;Exp. Dermatol.,2012
4. Hantute-Ghesquier, A., Haustrate, A., Prevarskaya, N., and Lehen’kyi, V. (2018). TRPM family channels in cancer. Pharmaceuticals, 11.
5. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis;Duncan;Cancer Res.,1998